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Abstract: 
Background  
The recently published MOMS-Trial suggested that open in utero repair is a 
novel standard of care for select fetuses with MMC. At the Zurich Center for 
Fetal Diagnosis and Therapy we carried out one of the first fetal MMC 
repairs outside the three US-Trial Centers that was performed in strict 
accord with the recently published criteria, principles, and procedures set 
forth by the quoted trial.  
 
Case Report  
A 37 y-old 4G3P was diagnosed at GA 19+3 with a fetus demonstrating a 
lumbosacral MMC (upper level L3). Since all criteria for eventual fetal 
repair were met, the parents were non-directively counseled and then 
opted for fetal surgery. The operation was successfully performed at GA 
24+5. The postoperative course of mother and fetus was uneventful except 
for leakage-induced oligohydramnios. The fetal middle cerebral artery peak 
velocity was moderately elevated for two weeks postoperatively suggesting 
fetal anemia. C-section was performed at GA 35 after premature rupture of 
membranes. At 8 months of life, a VP-shunt had to be placed. The 
peripheral neurology was determined as a mild to moderate paraparesis 
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(level L3/4). A bilateral hip dislocation due to prolonged breech 
presentation required surgery. There was no need for clean intermittent 
catheterization (CIC). Finally, the baby suffered from a kidney dysfunction 
of unclear origin.  
 
Conclusion  
We have adopted the novel and, more importantly, evidence-based 
treatment option resulting from the MOMS-trial and set the stage for a 
scientifically sound open fetal surgery program outside the US-Trial 
Centers. Maternal safety was perfectly preserved. Fetal problems possibly 
related to prenatal surgery comprised uneventful late preterm birth, 
oligohydramnios-related hip dislocations, and mild renal dysfunction. At 
one year of age, distinct benefits from fetal surgery include favorable leg 
motor function and avoidance of bladder catheterization.  
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Abstract 
 
Background 
The recently published MOMS-Trial suggested that open in utero repair is a novel 
standard of care for select fetuses with MMC. At the Zurich Center for Fetal Diagnosis and 
Therapy we carried out one of the first fetal MMC repairs outside the three US-Trial Centers 
that was performed in strict accord with the recently published criteria, principles, and 
procedures set forth by the quoted trial.  
 
Case Report 
A 37 y-old 4G3P was diagnosed at GA 19+3 with a fetus demonstrating a lumbosacral 
MMC (upper level L3). Since all criteria for eventual fetal repair were met, the parents were 
non-directively counseled and then opted for fetal surgery. The operation was successfully 
performed at GA 24+5. The postoperative course of mother and fetus was uneventful except 
for leakage-induced oligohydramnios. The fetal middle cerebral artery peak velocity was 
moderately elevated for two weeks postoperatively suggesting fetal anemia. C-section was 
performed at GA 35 after premature rupture of membranes. At 8 months of life, a VP-shunt 
had to be placed. The peripheral neurology was determined as a mild to moderate 
paraparesis (level L3/4). A bilateral hip dislocation due to prolonged breech presentation 
required surgery. There was no need for clean intermittent catheterization (CIC). Finally, the 
baby suffered from a kidney dysfunction of unclear origin. 
 
Conclusion 
We have adopted the novel and, more importantly, evidence-based treatment option 
resulting from the MOMS-trial and set the stage for a scientifically sound open fetal surgery 
program outside the US-Trial Centers. Maternal safety was perfectly preserved. Fetal 
problems possibly related to prenatal surgery comprised uneventful late preterm birth, 
oligohydramnios-related hip dislocations, and mild renal dysfunction. At one year of age, 
distinct benefits from fetal surgery include favorable leg motor function and avoidance of 
bladder catheterization. 
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Introduction 
The first description of apparently secondary, i.e. in utero acquired, damage to the 
pathologically exposed spinal cord within the myelomeningocele (MMC) lesion dates back to 
1956 (1). For obvious reasons, the significance of this observation regarding therapeutic 
consequences was not recognized until fetal surgery became a reality in the 1980ies (2). 
Only then was the hypothesis born that early in utero intervention might stop the ongoing 
neural tissue destruction and so reduce the neurologic deficit otherwise seen at birth (3).  
Compelling experimental (4; 5) as well as preliminary clinical (6-10) evidence collected 
over the past two decades have led to the conclusion that fetal surgery for MMC may be an 
effective novel therapy to ameliorate the neurologic outcome. Lastly, a recently published 
prospective, controlled, and randomized study (MOMS-Trial) (11) has, for the very first time, 
generated sound data showing that in utero repair can be recommended as a novel standard 
of care for selected fetuses with MMC. This is a report on the first fetus with MMC operated 
under the published criteria, principles, and procedures set forth by the MOMS-Trial at the 
Zurich Center for Fetal Diagnosis and Therapy.  
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Case report 
 
Diagnostic workup 
A healthy 37 year-old 4G3P was diagnosed with a female fetus suffering from a spina 
bifida in the 19th week of gestation. On ultrasound, the fetus had a classical cystic 
lumbosacral myelomeningocle (MMC) (cranial level = lumbar 3), the typical Chiari II 
malformation, and a moderate ventriculomegaly (13 mm). The fetus demonstrated bilateral 
lower extremity movements at hip, knee, ankle, and toe levels. The bladder showed normal 
cycling and the stomach was visible. No other malformations were identified. The placenta 
completely covered the anterior uterine wall. Fetal MRI at 19+4 weeks of gestational age 
confirmed these findings, but additionally revealed an aqueductal stenosis (Fig. 1a).  
In summary, both mother and fetus met all inclusion criteria for fetal surgical repair 
according to the MOMS-Trial while they did not fulfill any of the exclusion criteria (11). 
 
Prenatal counseling 
Parents were counseled non-directively in several sessions by pediatric surgeons, 
obstetricians, and anesthesiologists with particular focus on all known risks and potential 
benefits associated with maternal-fetal surgery and also with all problems and handicaps 
presumably present if standard postnatal care was chosen. They were given ample time for 
decision making and were also informed that whatever decision they made they could 
change at any time.  
The parents decided to pursue fetal surgery. A written informed consent was obtained. 
 
Maternal-fetal surgery 
Both maternal and fetal surgery were performed according to the current techniques 
used within the MOMS-Trial framework (11). Three days before the intervention lung 
maturation was induced with 24mg betamethasone. To prevent postoperative contractions, 
the mother received 50mg indomethacin preoperatively. The mother underwent deep 
inhalation anesthesia with desflurane, remifentanil and neuromuscular relaxation. A 
transverse supraumbilical laparotomy was performed, the uterus was exteriorized, and 
opened on the posterior wall at a safe distance from the placenta. The fetus was positioned 
in such a way that the cystic MMC-lesion came to lie within the hysterotomy.  
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The cystic sac was then resected taking care not to touch the exposed, non-
neurulated, but macroscopically intact, spinal cord tissue (Fig. 2a). The easily identifiable 
filum terminale was clearly under tension that was completely released after untethering. 
Since the open dura mater was difficult to identify, a bilateral paraspinal myofascial flap, 
medially comprising the open dura, was raised and sewn over the cord (Fig 2b). After 
extensive mobilization, the skin could be closed primarily over the defect (Fig 2c). Total fetal 
blood loss was an estimated 8 ml (~ 8-10% loss of total blood volume). 
Ultrasound monitoring showed normal heart rate and myocardial contractility of the 
fetus throughout the intervention.  
The uterus was closed using an inner running suture and outer single stitches. 
Amniotic fluid was substituted with 500 ml Ringer’s lactate containing 2 g of ceftriaxon as 
antibiotic prophylaxis. An omental flap was sewn over the closure site for additional sealing. 
The maternal laparotomy was closed in layers.  
In summary, the operation was performed without significant problems and the 
principle goals of the intervention including preserved maternal-fetal safety as well as solid 
multilayer defect closure over the non-touched intact spinal cord were reached. 
 
Postoperative maternal-fetal management and evolution 
To prevent contractions, an infusion with high dose magnesium was started (6 g 
loading dose, followed by 4 g/h for the first 3 h, then 3 g/h for the next 33 h) and the mother 
also received 3 doses of 50 mg indomethacin. After 3 days, a continuous long-term tocolysis 
was started using nifedipine 120 mg/d. For thromboprophylaxis we used low molecular 
heparin and pneumatic stockings. Epidural catheter analgesia allowed optimal pain control 
for the first 2 postoperative days. The mother was mobilized on postoperative day 2 and 
discharged home 4 weeks after the intervention.  
Continuous monitoring of fetal heart rate and uterine activity was normal throughout 
the postoperative course.  
A scan 6 h after the intervention demonstrated anhydramnios suggesting amniotic fluid 
leakage into the maternal peritoneal cavity although no free fluid was seen in the maternal 
abdomen. For the remainder of gestation, the fetus remained in the breech presentation with 
extended legs, already present preoperatively.  
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Postoperatively, peak velocity in the middle cerebral artery (MCA-PV) was 2.7 SD 
above mean values, indicating mild fetal anemia. It increased to 3.7 SD within one week and 
normalized by two weeks after the operation. Heart rate and myocardial contractility were 
always normal and there were no signs of fetal hydrops. The fetal bladder was almost empty 
for one week. Thereafter, normal cycling was again present and small pockets of amniotic 
fluid were detected. The amniotic fluid index remained below 5. The ventricle size was 11 
mm during the first 2 postoperative weeks but then gradually increased to 20mm prior to 
delivery. Hindbrain herniation reversed completely within 8 weeks (Fig 1b). Active feet and 
toe movements were present throughout. 
 
Cesarean section 
C-section was performed on a semi-elective basis at gestational age of 35+0 weeks, 
about 8 hours after rupture of membranes and onset of mild labour. There was no uterine 
dehiscence detectable. 
The baby girl (head circumference 32,5 cm [P:50-75], weight 2030 g  [P:10-25], length 
43 cm [P:3-10]) adapted normally (Apga  8/8/9). The repair site was solidly healed (Fig. 3). 
Due to prolonged breech presentation, legs and trunk were in a fixed jack-knife position. 
The mother exhibited an uneventful postoperative course and was discharged home on 
postoperative day 6.   
 
Postnatal clinical evolution during the first year of life 
The key features of the first 12 months post partum can be summarized as follows: 
Vital parameters were always normal. Regarding growth, the baby developed along the 3rd 
percentile for length and body weight. Peripheral neurology showed a mild to moderate 
paraparesis below L4 representing a more favourable motor capacity than usually expected 
when compared to similar postnatal repair. 
With regard to hydrocephalus, head circumference increased gradually from the 
percentile P3 (birth) to P50 (6 months) without clinically significant signs of increased 
cerebral pressure. Over the ensuing 2 months, the baby demonstrated an overproportional 
growth of the neurocranium, developed mild signs for increased cerebral pressure, and head 
circumference crossed P90. Repeat MRI demonstrated significant ventriculomegaly (Fig 4), 
in all likelihood due to the still present aqueductal stenosis (present already before fetal 
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surgery!), while hindbrain herniation was still reversed. At 8 months of life, a ventriculo-
peritoneal shunt was therefore inserted with an uneventful postoperative course up to date.  
Urologically, the baby is voiding spontaneously under a regimen of oxybutinin 
installation twice a day.  
The baby demonstrated a renal insufficiency with the highest creatinin level of 273 
µmol/l at day 5 of life that gradually decreased to 48 µmol/l (normal range <35 µmol/l ) at the 
age of 11 months. Despite an extensive diagnostic workup, the reason for this kidney 
dysfunction could not be conclusively determined.  
Defecation occurres spontaneously and on a regular basis without soiling. 
Finally, a bilateral hip dislocation, consequent to the fetal breech position (present 
before fetal surgery) was reduced surgically at 4 months of life after casting failed. 
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Discussion 
This is one of the first open fetal spina bifida repairs conducted outside the USA. More 
importantly, it is, to the best of our knowledge, the first intervention performed outside the 
three US-trial centers after the ground breaking evidence resulting from the “Management of 
Myelomeningocele Study” (MOMS) clinical trial was published (11). Of note, this “premiere” 
surgery was carefully orchestrated with our partner institution, the Center for Fetal Diagnosis 
and Treatment of the Children’s Hospital of Philadelphia. In particular, the current concepts, 
guidelines, and standard operating procedures of the MOMS-Trial regarding prenatal 
diagnostic workup, maternal-fetal surgery, and postoperative management were adopted 
(11). Importantly, one of the world’s most experienced fetal surgeons (co-author AWF, 
Philadelphia) assisted the operation and acted as advisor during the critical perioperative 
phase. It is our firm conviction that the latter is an indispensable strategic element to 
guarantee the best possible setting for this most sophisticated and extremely demanding 
enterprise. Clearly, a failure to organize the best expertise is hardly justifiable medically and 
ethically in front of patient and mother, and, moreover, it jeopardizes the successful spawn of 
this youngest surgical discipline to a few more select centers. 
Definitely, the aforementioned MOMS-Trial is by far the largest prospective, 
randomized clinical trial ever carried out to compare prenatal versus postnatal surgery. And it 
is the first to convincingly demonstrate a clear cut benefit for the fetal surgery cohort in that 
almost all crucial outcome parameters were clearly in favor of in utero intervention as 
opposed to conventional postnatal care (11). Of note, the unequivocal results even led to a 
premature ending of the trial after 183 out of the planned 200 patients were enrolled. 
The key findings of the MOMS-Trial were that fetal surgery markedly reduced the need 
for hydrocephalus shunting (fetal surgery 40% vs. postnatal care 82%) and significantly 
improved motor as well as developmental outcomes at 30 months. On the other hand, fetal 
surgery was associated with a higher risk of preterm delivery and uterine dehiscence at 
delivery (11). 
 We found similar advantageous effects in our case, in particular complete reversal of 
hindbrain herniation, spontaneous micturition with no need for clean intermittent 
catheterization, and a better than expected peripheral neurology. Although these findings are 
substantial benefits attributable in all likelihood to prenatal intervention, they are somewhat 
preliminary since the follow-up period is only one year. 
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The need for late ventriculo-peritoneal shunting at 8 months of life calls for a judicious 
consideration. The hindbrain herniation, present preoperatively, resolved almost completely 
before birth as typically seen after fetal surgery (11-15). During the first 6 months there was a 
slightly overproportional head growth and there were no signs for increased intracranial 
pressure (ICP). Therefore, we expected a high likelihood that shunting would not be 
mandatory. Somewhat surprisingly, we then witnessed an unfavorable evolution with 
increasing signs for elevated ICP and a head circumference that rapidly crossed the 97th 
percentile mandating shunt placement. Here, the question arises whether shunting was 
required because of aqueductal stenosis, identified before fetal surgery. We did not find any 
current literature describing an association between MMC and aqueductal stenosis. 
Therefore, it remains unclear whether this patient is a true non-responder regarding shunt 
avoidance after fetal surgery (like the 40% of the MOMS Trial) or whether it was a rather 
unfortunate and uncommon coincidence of spina bifida and aqueductal stenosis leading to 
aqueductal stenosis-induced/co-induced hydrocephalus (16).  
Another issue is the leakage-induced oligohydramnios (also seen in 21% of the 
MOMS-Trial fetal surgery cases) and its possible negative impact. Apparently, there was no 
clinically significant effect on lung development and function in that the baby demonstrated 
normal respiration at all times. Likewise, oligohydramnios has probably not played a major 
role in the pathogenesis of hip dislocation. Rather, this pathology is a consequence of the 
breech presentation the fetus demonstrated already before fetal intervention.  
A completely unexpected finding was a marked transient renal insufficiency of unclear 
origin. We hypothesize that a combined effect of indomethacin (17; 18) (via renal artery 
constriction) and anemia, another drug-related side effect, or a non procedure-related cause 
(e.g. hypodysplastic kidneys) might have played a role. Despite extensive investigation we 
could not find enough evidence to corroborate either explication, although a pharmacological 
problem is most likely. Moreover, there is no report on procedure-related kidney problems in 
the context of fetal surgery. 
Of utmost importance, maternal safety was perfectly preserved as there were no 
significant problems or complications throughout the entire course.  
 
In summary, we report on our first case successfully managed in accord with the 
recently published MOMS-Trial framework and provide preliminary outcome data. Although in 
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utero surgery can now be recommended as new standard of care for select fetuses with 
MMC, the paucity of cases as well as both delicacy and intricacy of fetal surgery mandate 
these patients be pooled in a few centers worldwide and the interventions be exclusively 
performed by appropriately trained and highly qualified fetal surgeons. 
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Figure 1  
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Legend for figures: 
 
Figure 1 
a) preoperative fetal MRI at 20 weeks of gestation. Sagittal single shot fast spin echo sequence 
showing the MMC lesion (asterisk) with associated hindbrain herniation (white arrow) and 
ventriculomegaly. 
b) postoperative fetal MRI at 34 weeks of gestation. Sagittal single shot fast spin echo sequence 
showing an intact MMC closure side. The hindbrain herniation is reversed. Dysplastic mesencephalic 
tectum. 
 
Figure 2 
a) MMC lesion 
b) Closure of the dura mater 
c) fetal skin closure 
 
Figure 3 
Picture taken immediately after birth showing a healed wound and covered spina bifida. 
 
Figure 4 
MRI at the 8 month of age; Sagittal T2-weighted fast spin echo sequence: Small posterior fossa, no 
cerebellar herniation. Dysplastic mesencephalic tectum and missing flow void at the level of the 
cerebral aqueduct (arrow). 
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